| Heart disease and stroke statistics—2014 update: a report from the American Heart Association AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ... circulation 129 (3), e28-e292, 2014 | 77805* | 2014 |
| Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men PM Ridker, M Cushman, MJ Stampfer, RP Tracy, CH Hennekens New England journal of medicine 336 (14), 973-979, 1997 | 8089 | 1997 |
| Heart disease and stroke statistics 2005 update American Heart Association http://www. americanheart. org/statistics/, 2005 | 5505* | 2005 |
| Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid … T Antihypertensive, ... Jama 288 (23), 2981-2997, 2002 | 5420* | 2002 |
| COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review B Bikdeli, MV Madhavan, D Jimenez, T Chuich, I Dreyfus, E Driggin, ... Journal of the American college of cardiology 75 (23), 2950-2973, 2020 | 3664 | 2020 |
| Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association JC Hemphill III, SM Greenberg, CS Anderson, K Becker, BR Bendok, ... Stroke 46 (7), 2032-2060, 2015 | 3395 | 2015 |
| Major lipids, apolipoproteins, and risk of vascular disease R Assessment Jama 302 (18), 1993-2000, 2009 | 3367 | 2009 |
| C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis Emerging Risk Factors Collaboration The Lancet 375 (9709), 132-140, 2010 | 3142 | 2010 |
| Estrogen plus progestin and the risk of coronary heart disease JAE Manson, J Hsia, KC Johnson, JE Rossouw, AR Assaf, NL Lasser, ... New England Journal of Medicine 349 (6), 523-534, 2003 | 2812 | 2003 |
| Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the … MR Jaff, MS McMurtry, SL Archer, M Cushman, N Goldenberg, ... Circulation 123 (16), 1788-1830, 2011 | 2657 | 2011 |
| Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis Ankle Brachial Index Collaboration JAMA: the journal of the American Medical Association 300 (2), 197, 2008 | 2534 | 2008 |
| Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association G Saposnik, F Barinagarrementeria, RD Brown Jr, CD Bushnell, ... Stroke 42 (4), 1158-1192, 2011 | 2457 | 2011 |
| Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines SR Kahn, W Lim, AS Dunn, M Cushman, F Dentali, EA Akl, DJ Cook, ... Chest 141 (2), e195S-e226S, 2012 | 2207 | 2012 |
| Incidence of and risk factors for atrial fibrillation in older adults BM Psaty, TA Manolio, LH Kuller, RA Kronmal, M Cushman, LP Fried, ... Circulation 96 (7), 2455-2461, 1997 | 2056 | 1997 |
| Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis FS Collaboration Jama 294 (14), 1799-1809, 2005 | 1764 | 2005 |
| Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease PM Ridker, M Cushman, MJ Stampfer, RP Tracy, CH Hennekens Circulation 97 (5), 425-428, 1998 | 1688 | 1998 |
| Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies AM Wood, S Kaptoge, AS Butterworth, P Willeit, S Warnakula, T Bolton, ... The Lancet 391 (10129), 1513-1523, 2018 | 1528 | 2018 |
| C-reactive protein, fibrinogen, and cardiovascular disease prediction Emerging Risk Factors Collaboration New England Journal of Medicine 367 (14), 1310-1320, 2012 | 1452 | 2012 |
| The reasons for geographic and racial differences in stroke study: objectives and design VJ Howard, M Cushman, LV Pulley, CR Gomez, RC Go, RJ Prineas, ... Neuroepidemiology 25 (3), 135-143, 2005 | 1321 | 2005 |
| World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions S Kaptoge, L Pennells, D De Bacquer, MT Cooney, M Kavousi, G Stevens, ... The Lancet global health 7 (10), e1332-e1345, 2019 | 1294 | 2019 |
George Howardprofessor of biostatisticsVerified email at uab.edu
